Group Pushes Bill To Increase Female Representation In Device Clinical Trials
This article was originally published in The Gray Sheet
Executive Summary
The National Coalition for Women with Heart Disease is pressing lawmakers to pass a bill that would encourage more equal representation of women in clinical trials for cardiovascular devices.
You may also be interested in...
Study Finds Heart Device Trials Male-Dominated; FDA Promises Guidance
Women remain underrepresented in pivotal studies of cardiac devices submitted to FDA, and there is a lack of analysis distinguishing between trial outcomes in men and women, researchers conclude in a study published online March 1.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.